Summary
GlobalData's clinical trial report, “Xerosis (Dry Skin) Global Clinical Trials Review, H2, 2018" provides an overview of Xerosis (Dry Skin) clinical trials scenario. This report provides top line data relating to the clinical trials on Xerosis (Dry Skin). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Pierre Fabre Foundation
Johnson & Johnson
Galderma SA
TTC Co., Ltd.
TKL Research Inc
Noevir Holdings Co Ltd
L'Oreal SA
Diomed Developments Ltd
Alchem Laboratories Corp
Alba Science Ltd
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Clinical Trials by G7 Countries: Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Xerosis (Dry Skin) Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 65
Contact Us 66
Source 66
List of Tables
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Xerosis (Dry Skin) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Xerosis (Dry Skin) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Xerosis (Dry Skin) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, G7 Countries (%), 2018* 15
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
Xerosis (Dry Skin) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Xerosis (Dry Skin) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Xerosis (Dry Skin) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32
List of Figures
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Xerosis (Dry Skin) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Xerosis (Dry Skin) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Xerosis (Dry Skin) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, G7 Countries (%), 2018* 14
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
Xerosis (Dry Skin) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Xerosis (Dry Skin) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Xerosis (Dry Skin) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32
GlobalData Methodology 65
